Colchicine in Patients with Coronary Artery Disease with or Without Diabetes Mellitus: A Meta-analysis of Randomized Clinical Trials.
Michał KuzemczakAbdalazeem IbrahemMohammad AlkhalilPublished in: Clinical drug investigation (2021)
This meta-analysis underscores the heightened inflammatory risk associated with diabetes and highlights the need to target inflammatory pathways in these individuals irrespective of glucose-lowering drugs.